WealthPLAN Partners’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
GC
SM
PC
KCM
WealthPLAN Partners's DVAX Position: Q2 2017 in Review
WealthPLAN Partners sold out of Dynavax Technologies (DVAX) in Q2 2017, closing a stake of 600 shares — an estimated $3.09K sold.
WealthPLAN Partners first reported a position in DVAX in Q4 2015 and held it in 4 quarters. The position peaked at $8.76K in Q2 2016. 111 funds tracked by Wall St. Rank hold DVAX as of Q2 2017.
- WealthPLAN Partners reported no remaining Dynavax Technologies position as of Q2 2017 after selling out during the quarter.
- WealthPLAN Partners sold 600 Dynavax Technologies shares in Q2 2017, an estimated $3.09K.
- WealthPLAN Partners first reported a position in Dynavax Technologies in Q4 2015 and held it in 4 quarters.
- WealthPLAN Partners's Dynavax Technologies position peaked at $8.76K in Q2 2016.
- 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2017.
Based on WealthPLAN Partners's 13F filing for Q2 2017, filed 11 Aug 2017.